About OGRIX
Invesco Comstock Select Fund R6 is a US equity mutual fund focused on long-term capital growth and current income, achieved predominantly through investments in common stocks considered undervalued based on low price-to-earnings ratios and the potential for better-than-anticipated earnings. The fund employs a high-conviction, bottom-up, and benchmark-agnostic approach, selectively investing across all sectors in North American markets. Its process prioritizes deep fundamental analysis over index replication, frequently resulting in a portfolio that diverges notably from major benchmarks and its peer group.
As a multi-cap value fund, Invesco Comstock Select Fund R6 typically holds a concentrated portfolio—around 30 holdings—with a significant proportion of assets allocated to its top positions. Key industry sectors represented include financial services, healthcare, and consumer goods, with prominent holdings such as Bank of America, CVS Health, and Huntington Bancshares. The fund is designed for investors seeking exposure to large and mid-cap US companies with perceived undervalued business fundamentals, and it balances the pursuit of capital appreciation with the generation of current income, though income is a secondary objective. Managed by Invesco, one of the largest global investment management firms, the fund also maintains a competitive fee structure within its category.
Fund Family Invesco
Category Large Value
Performance Rating Above Average
Risk Rating High
Stock Exchange NASDAQ
Ticker Symbol OGRIX
Index Russell 1000 Value TR
OGRIX had a total return of 21.11% in the past year, including dividends.
Since the fund's inception, the average annual return has been 11.29%.
